Neurobiology of Opioid Dependence: 5 - 5
NCT00000196 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-06-03
Summary
The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
Conditions
- Opioid-Related Disorders
Interventions
- DRUG
-
Naltrexone
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Marc I Rosen, M.D. · VA Connecticut Healthcare System
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-01-31
- Primary Completion
- 1998-01-31
- Completion
- 1998-01-31
Countries
- United States
Study Locations
More Related Trials
-
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
NCT03169816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent
NCT03681769 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sensory Outcomes in Active Substance Users
NCT06639438 ·Status: RECRUITING
-
Clinical Trials of Multivalent Opioid Vaccine Components
NCT04458545 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Nicotine on Brain Opioid Receptors
NCT01040338 ·Status: TERMINATED
-
Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence
NCT02437344 ·Status: COMPLETED ·Phase: PHASE2
-
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
NCT04287062 ·Status: COMPLETED ·Phase: PHASE2
-
Employment-based Reinforcement of Naltrexone Ingestion and Abstinence
NCT00149669 ·Status: COMPLETED ·Phase: NA
-
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
NCT04464980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction
NCT00521157 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
NCT05463367 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Buprenorphine Dose Alteration Study - 1
NCT00000219 ·Status: COMPLETED ·Phase: PHASE1
-
Dronabinol Naltrexone Treatment for Opioid Dependence
NCT01024335 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
NCT01502644 ·Status: COMPLETED ·Phase: PHASE4
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
NCT05336188 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Oxytocin Treatment of Opioid Dependence
NCT02548728 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
NCT03958474 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder
NCT05042388 ·Status: COMPLETED ·Phase: NA